(INCY) Incyte - Performance 12.3% in 12m
Compare INCY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-39.46%
#58 in Group
Rel. Strength
70.80%
#2337 in Universe
Total Return 12m
12.29%
#39 in Group
Total Return 5y
-43.68%
#58 in Group
P/E 388
100th Percentile in Group
P/E Forward 9.62
42th Percentile in Group
PEG 0.37
75th Percentile in Group
FCF Yield 2.57%
83th Percentile in Group
12m Total Return: INCY (12.3%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: INCY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for INCY
Total Return (including Dividends) | INCY | XBI | S&P 500 |
---|---|---|---|
1 Month | -7.61% | -10.94% | -6.73% |
3 Months | -20.03% | -14.92% | -11.93% |
12 Months | 12.29% | -6.46% | 7.24% |
5 Years | -43.68% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | INCY | XBI | S&P 500 |
1 Month | -77.7% | -52.8% | -63.5% |
3 Months | -88.7% | -92.8% | -90.3% |
12 Months | 48.5% | -32.4% | 60.6% |
5 Years | -76.2% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #87 | 3.74% | -0.94% |
3 Month | #87 | -6.01% | -9.20% |
12 Month | #41 | 20.1% | 4.72% |
5 Years | #56 | -30.3% | -71.9% |
FAQs
Does INCY Incyte outperforms the market?
Yes,
over the last 12 months INCY made 12.29%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months INCY made -20.03%, while XBI made -14.92%.
Over the last 3 months INCY made -20.03%, while XBI made -14.92%.
Performance Comparison INCY vs Indeces and Sectors
INCY vs. Indices INCY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -1.39% | -0.88% | -4.23% | 5.05% |
US NASDAQ 100 | QQQ | -1.87% | -0.25% | -4.37% | 4.70% |
US Dow Jones Industrial 30 | DIA | 0.64% | -0.70% | -4.85% | 7.80% |
German DAX 40 | DAX | -2.61% | -3.67% | -24.1% | -8.04% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.82% | -4.22% | -5.38% | 3.08% |
Hongkong Hang Seng | HSI | -4.06% | -3.89% | -8.77% | -4.49% |
India NIFTY 50 | INDA | -3.54% | -9.64% | -7.58% | 9.30% |
Brasil Bovespa | EWZ | -5.66% | -8.07% | -9.28% | 21.0% |
INCY vs. Sectors INCY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.10% | -0.76% | -13.4% | -2.78% |
Consumer Discretionary | XLY | -2.83% | -0.77% | -9.53% | 1.0% |
Consumer Staples | XLP | -1.54% | -10.6% | -12.2% | 0.96% |
Energy | XLE | -1.46% | 4.89% | -2.93% | 25.0% |
Financial | XLF | -2.09% | -2.76% | -13.1% | -5.54% |
Health Care | XLV | 0.88% | 0.15% | -2.01% | 14.7% |
Industrial | XLI | -0.79% | -1.58% | -4.06% | 8.23% |
Materials | XLB | -1.13% | -1.76% | 3.03% | 18.2% |
Real Estate | XLRE | -1.16% | -4.38% | -3.88% | -2.44% |
Technology | XLK | -1.66% | 1.39% | 2.01% | 11.1% |
Utilities | XLU | -1.28% | -7.81% | -7.86% | -9.39% |
Aerospace & Defense | XAR | 0.06% | -4.43% | -13.6% | -9.58% |
Biotech | XBI | -4.81% | 3.33% | 7.17% | 18.8% |
Homebuilder | XHB | -2.92% | 0.51% | 10.5% | 22.8% |
Retail | XRT | -3.26% | -2.22% | -0.79% | 18.6% |